Clinical Trial Update: Efficacy of Repeated Ketamine Infusions for Treatment-resistant Depression [Phase 2]

View source ↗

Summary

Phase 2 trial of repeated ketamine infusions demonstrates efficacy in treatment-resistant depression. The results were posted on December 3, 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Treatment-resistant Depression | Phase 2 | Status: COMPLETED | Results posted: 2019-12-03